Neuroendovascular Non-Coils Market Size 2025-2029
The neuroendovascular non-coils market size is forecast to increase by USD 419.7 million, at a CAGR of 4.6% between 2024 and 2029.
- The market is driven by the increasing incidence of intracranial aneurysms and growing awareness and education about these conditions. Neuroendovascular non-coils are essential tools in the treatment of intracranial aneurysms, making this market a significant player in neurovascular healthcare. However, the market faces challenges due to stringent regulations associated with the approval of these devices. The regulatory process is lengthy and complex, requiring extensive clinical trials and data to ensure safety and efficacy. This not only increases the cost of bringing new products to market but also slows down innovation. Companies in the market must navigate these regulatory hurdles while continuing to invest in research and development to meet the evolving needs of patients and healthcare providers.
- To capitalize on market opportunities and navigate challenges effectively, companies must stay informed of regulatory changes, collaborate with regulatory agencies, and invest in robust clinical trial programs. By doing so, they can bring innovative and effective neuroendovascular non-coil devices to market, addressing the growing demand for advanced treatments for intracranial aneurysms.
What will be the Size of the Neuroendovascular Non-Coils Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market continues to evolve as researchers and medical professionals explore innovative solutions for stroke intervention and the treatment of various neurovascular conditions. The application of these technologies extends beyond aneurysm rupture to include the management of vascular malformations and atherosclerotic plaque. Endovascular repair techniques, such as embolization and flow diverter stent deployment, are increasingly utilized due to their procedural safety and efficacy. Angiographic imaging and surgical navigation systems enable precise targeting of lesions, reducing complication rates and enhancing neurological outcomes. Drug delivery systems and targeted therapy are also gaining traction in the neuroendovascular space, offering new possibilities for thrombosis treatment and vessel occlusion.
Neurovascular imaging and intracranial aneurysm assessment play a crucial role in surgical planning and endovascular access. Microsurgical techniques and embolization materials continue to advance, providing alternatives to traditional coiling methods. The ongoing unfolding of market activities reveals a focus on improving patient recovery and minimizing risks associated with neurovascular interventions. Brain arteriovenous malformations and aneurysm rupture are among the conditions that benefit from these advancements. Device deployment and neurological outcomes remain key areas of interest, with ongoing research aimed at optimizing treatment efficacy and minimizing complications. The market demonstrates a continuous drive for innovation, as medical professionals and researchers seek to address the complexities of neurovascular conditions and improve patient outcomes.
How is this Neuroendovascular Non-Coils Industry segmented?
The neuroendovascular non-coils industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- Product Type
- Neuroendovascular stents
- Access devices
- Flow diversion devices
- Thrombectomy devices
- Embolic protection devices
- Balloon catheters
- Liquid embolic agents
- Others
- End-user
- Hospitals
- Ambulatory surgical centers (ASCs)
- Stroke centers
- Specialty clinics
- Others
- Application
- Ischemic stroke
- Arteriovenous malformation (AVM)
- Aneurysm treatment
- Carotid artery disease
- Venous sinus thrombosis
- Tumor embolization
- Procedure Type
- Endovascular embolization
- Thrombectomy
- Angioplasty and stenting
- Flow diversion
- Tumor embolization
- Material Type
- Nitinol-based devices
- Cobalt-chromium-based devices
- Polymer-based devices
- Others
- Geography
- North America
- Europe
- APAC
- China
- India
- Japan
- South Korea
- South America
- Rest of World (ROW)
By Product Type Insights
The neuroendovascular stents segment is estimated to witness significant growth during the forecast period.
Neuroendovascular stents are essential medical devices in neurointerventional procedures, addressing cerebrovascular conditions like aneurysms and stenosis. Technological advancements have led to improved stent designs and biocompatible materials, ensuring better patient outcomes and reduced complications. Newer alloys and bioresearchable polymers have been instrumental in enhancing stent efficacy and safety, thereby bolstering healthcare professionals' confidence in their use. The global prevalence of cerebrovascular diseases continues to rise, fueling the demand for effective treatment modalities such as neuroendovascular stents. Risk factors, including sedentary lifestyles, high blood pressure, and smoking, contribute to the increasing incidence of conditions like cerebral aneurysms and carotid artery stenosis, particularly in the aging population.
In neuroendovascular procedures, drug delivery systems have emerged as a valuable adjunct to stent deployment, enabling targeted therapy for various cerebrovascular conditions. Procedural safety is a critical concern, with advancements in surgical navigation and embolic protection systems playing a pivotal role in minimizing complications. Endovascular repair techniques, including aneurysm embolization and vessel occlusion, have gained popularity due to their minimally invasive nature and improved neurological outcomes. Angiographic imaging and neurovascular imaging have significantly impacted the diagnosis and treatment planning process, allowing for precise identification of lesion characteristics and optimal device deployment. Microsurgical techniques and endovascular access methods continue to evolve, expanding the therapeutic options for treating complex cerebrovascular conditions.
Flow diverter stents have emerged as coiling alternatives for treating intracranial aneurysms, offering advantages such as improved blood flow and reduced risk of aneurysm recurrence. Neurovascular devices, including flow diverters and embolization materials, have shown promising results in treating vascular malformations and thrombosis. Stroke intervention strategies have evolved to include endovascular surgery, with neuroendovascular stents playing a crucial role in restoring blood flow and improving patient recovery. Despite advancements, complications such as thrombosis and device deployment-related issues remain concerns. Continuous research and development efforts are underway to address these challenges and improve treatment efficacy, ensuring optimal patient outcomes.
Request Free Sample
The Neuroendovascular stents segment was valued at USD 566.50 million in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
The market in North America is experiencing steady growth due to the increasing prevalence of vascular diseases, such as aneurysms and cerebral hemorrhage, and the rising demand for minimally invasive procedures. Advanced technologies, including drug delivery systems, flow diverter stents, and surgical navigation, are enhancing procedural safety and improving neurological outcomes. Endovascular repair techniques, such as aneurysm embolization and thrombosis treatment, are gaining popularity over traditional microsurgical techniques. Targeted therapy and embolic protection systems are also emerging as effective alternatives for treating atherosclerotic plaque and vascular malformations. The market is further propelled by the availability of advanced neurovascular imaging and angiographic imaging technologies, enabling accurate diagnosis and surgical planning.
Despite the benefits, the market faces challenges, including high complication rates and treatment efficacy concerns. Nonetheless, ongoing research and development efforts are expected to address these challenges and drive market growth. For instance, intracranial aneurysm rupture affects around 30,000 people annually in the US, creating a significant demand for advanced neuroendovascular devices and techniques.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Neuroendovascular Non-Coils Industry?
- The rising prevalence of intracranial aneurysms serves as the primary market driver.
- The market is experiencing significant growth due to the increasing prevalence of intracranial aneurysms. These devices provide an advanced treatment solution for managing complex and large aneurysms that are difficult to treat with traditional methods. The expanding patient pool, driven by a higher number of diagnosed intracranial aneurysms, is fueling market demand. Neuroendovascular non-coil devices offer a minimally invasive alternative to surgical clipping, making it an attractive treatment option for eligible patients. This less invasive procedure contributes to improved patient recovery and reduced hospital stays. Advancements in angiographic imaging and microsurgical techniques have facilitated the accurate identification and treatment of aneurysms, further driving market growth.
- Thrombosis treatment using neuroendovascular non-coils is a targeted therapy that limits damage to surrounding healthy tissue, enhancing patient outcomes. The use of embolization materials in endovascular access procedures has revolutionized neurointerventional treatments, offering a more precise and effective approach to aneurysm management. Overall, the market is poised for continued growth as the medical community seeks to provide optimal care for patients with intracranial aneurysms.
What are the market trends shaping the Neuroendovascular Non-Coils Industry?
- The increasing importance of intracranial aneurysm awareness and education represents a significant market trend. Two key areas of focus are heightened public awareness and continuous professional development for healthcare providers.
- The market is experiencing significant growth due to increased awareness and education about intracranial aneurysms and the availability of advanced treatment options. As patients and healthcare providers become more informed, the demand for effective neurovascular devices, such as non-coils, increases. Early detection of intracranial aneurysms leads to better treatment outcomes and a higher likelihood of successful flow diversion procedures. Patients are increasingly seeking minimally invasive treatment methods, including neuroendovascular surgery, and are requesting the use of non-coils as alternatives to traditional coiling techniques.
- Neuroimaging technologies, such as magnetic resonance angiography (MRA) and computed tomography angiography (CTA), enable more precise surgical planning and improved visualization of the vessel occlusion and vascular malformation. These factors collectively contribute to the market's growth and continued innovation in neuroendovascular devices.
What challenges does the Neuroendovascular Non-Coils Industry face during its growth?
- The stringent regulatory approvals process for neuroendovascular non-coil devices poses a significant challenge to the industry's growth. This challenge arises from the need to meet rigorous regulations in order to bring new devices to market. These regulations ensure patient safety and efficacy, but they can add time and cost to the development process. Consequently, companies must invest heavily in research and development, clinical trials, and regulatory compliance to remain competitive in the neuroendovascular market.
- Neuroendovascular non-coil devices play a significant role in stroke intervention by enabling effective treatment of various lesion characteristics, such as aneurysms and brain arteriovenous malformations. The regulatory approval process is a critical factor in the availability and adoption of these devices in countries like the US, Australia, and the UK. This process involves stringent scrutiny to ensure the safety, efficacy, and quality of the devices through preclinical testing and clinical trials.
- Complication rates and neurological outcomes following device deployment are closely monitored to assess treatment efficacy. Regulatory approvals are essential for market access and patient care, making this process a crucial aspect of the neuroendovascular non-coil market dynamics.
Exclusive Customer Landscape
The neuroendovascular non-coils market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the neuroendovascular non-coils market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, neuroendovascular non-coils market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
BALT Group - The company specializes in neuroendovascular non-coil systems, including Optima and OptiMAX, designed for endovascular intervention in the peripheral and neurovasculature to obstruct or occlude blood flow.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- BALT Group
- Cook Group Inc.
- Johnson and Johnson
- Kaneka Corp.
- Medtronic Plc
- Penumbra Inc.
- Rapid Medical Ltd.
- Shape Memory Medical Inc.
- Stryker Corp.
- Terumo Corp.
- Wallby Medical LLC
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Neuroendovascular Non-Coils Market
- In January 2024, Medtronic plc, a global healthcare solutions company, announced the U.S. Food and Drug Administration (FDA) approval of its new neurovascular device, the Marquis⢠Retrievable Stent System. This device is designed for the removal of large, complex intracranial aneurysms and is an addition to Medtronic's Neurovascular portfolio (Medtronic Press Release, 2024).
- In March 2024, Stryker Corporation, a leading medical technology company, entered into a strategic partnership with Neuravi Ltd., a UK-based neurovascular device company. This collaboration aimed to develop and commercialize Neuravi's innovative flow diverter technology, which is used in the treatment of complex intracranial aneurysms (Stryker Corporation Press Release, 2024).
- In May 2024, Merit Medical Systems, Inc., a global healthcare solutions provider, completed the acquisition of Neuronetics, Inc., a neuroscience and neuromodulation company. This acquisition expanded Merit Medical's portfolio to include Neuronetics' proprietary SpheRix⢠Neurovascular System, a minimally invasive technology used in the treatment of cerebral aneurysms (Merit Medical Systems, Inc. Press Release, 2024).
- In February 2025, MicroVention, Inc., a neurovascular device company, received CE Mark approval for its Pipeline Flex⢠Embolization Device, an advanced neurovascular device used for the treatment of wide-necked and large-volume intracranial aneurysms. This approval marked the first CE Mark for a neurovascular device with a 3D-printed braided design (MicroVention, Inc. Press Release, 2025).
Research Analyst Overview
- The neuroendovascular non-coil market is witnessing significant advancements in technology and treatment approaches for managing complex neurovascular conditions. Surgical planning software plays a crucial role in enhancing the accuracy and efficiency of neurointerventional procedures. Thromboembolic events remain a major concern, necessitating stringent treatment selection criteria based on lesion size assessment and patient selection. Microcatheter technology enables precise access to intracranial anatomies, while material properties and perfusion pressure impact procedural success rates. Clinical outcomes and treatment duration are critical factors influencing market trends. Stent deployment techniques and embolization agents continue to evolve, with a focus on minimizing hemorrhage control risks and improving patient monitoring.
- Device design, angiographic guidance, and imaging modalities are essential for optimizing device compatibility and minimizing re-treatment rates. Neurological deficits and recovery time are significant concerns for patients undergoing neuroendovascular procedures. Ischemic injury and endovascular workflow are key areas of research, with a growing emphasis on minimizing neurological damage and streamlining procedures. Anatomical variations and vascular access methods pose challenges, necessitating innovative solutions for hemorrhage control and post-procedural care. Clinical trials and neuroradiology techniques are essential for evaluating the safety and efficacy of new devices and procedures. Re-treatment rates and procedural success rates are closely monitored to ensure optimal patient outcomes.
- The market is expected to continue evolving, driven by advancements in technology, clinical research, and a growing focus on minimally invasive treatments for neurovascular conditions.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Neuroendovascular Non-Coils Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
215
|
|
Base year
|
2024
|
|
Historic period
|
2019-2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 4.6%
|
|
Market growth 2025-2029
|
USD 419.7 million
|
|
Market structure
|
Concentrated
|
|
YoY growth 2024-2025(%)
|
4.4
|
|
Key countries
|
US, Germany, China, Japan, Canada, UK, France, India, Brazil, and South Korea
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Neuroendovascular Non-Coils Market Research and Growth Report?
- CAGR of the Neuroendovascular Non-Coils industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the neuroendovascular non-coils market growth of industry companies
We can help! Our analysts can customize this neuroendovascular non-coils market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Neuroendovascular Non-Coils Market 2019 - 2023
- Historic Market Size - Data Table on Global Neuroendovascular Non-Coils Market 2019 - 2023 ($ million)
- 5.2 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
- 5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on global neuroendovascular non-coils market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product Type
- 8.1 Market segments
- Chart on Product Type - Market share (2024-2029) (%)
- Data Table on Product Type - Market share (2024-2029) (%)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
- 8.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)
- 8.3 Neuroendovascular stents - Market size and forecast (2024-2029)
- Chart on Neuroendovascular stents - Market size and forecast (2024-2029) ($ million)
- Data Table on Neuroendovascular stents - Market size and forecast (2024-2029) ($ million)
- Chart on Neuroendovascular stents - Year-over-year growth (2024-2029) (%)
- Data Table on Neuroendovascular stents - Year-over-year growth (2024-2029) (%)
- 8.4 Access devices - Market size and forecast (2024-2029)
- Chart on Access devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Access devices - Market size and forecast (2024-2029) ($ million)
- Chart on Access devices - Year-over-year growth (2024-2029) (%)
- Data Table on Access devices - Year-over-year growth (2024-2029) (%)
- 8.5 Flow diversion devices - Market size and forecast (2024-2029)
- Chart on Flow diversion devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Flow diversion devices - Market size and forecast (2024-2029) ($ million)
- Chart on Flow diversion devices - Year-over-year growth (2024-2029) (%)
- Data Table on Flow diversion devices - Year-over-year growth (2024-2029) (%)
- 8.6 Thrombectomy devices - Market size and forecast (2024-2029)
- Chart on Thrombectomy devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Thrombectomy devices - Market size and forecast (2024-2029) ($ million)
- Chart on Thrombectomy devices - Year-over-year growth (2024-2029) (%)
- Data Table on Thrombectomy devices - Year-over-year growth (2024-2029) (%)
- 8.7 Embolic protection devices - Market size and forecast (2024-2029)
- Chart on Embolic protection devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Embolic protection devices - Market size and forecast (2024-2029) ($ million)
- Chart on Embolic protection devices - Year-over-year growth (2024-2029) (%)
- Data Table on Embolic protection devices - Year-over-year growth (2024-2029) (%)
- 8.8 Balloon catheters - Market size and forecast (2024-2029)
- Chart on Balloon catheters - Market size and forecast (2024-2029) ($ million)
- Data Table on Balloon catheters - Market size and forecast (2024-2029) ($ million)
- Chart on Balloon catheters - Year-over-year growth (2024-2029) (%)
- Data Table on Balloon catheters - Year-over-year growth (2024-2029) (%)
- 8.9 Liquid embolic agents - Market size and forecast (2024-2029)
- Chart on Liquid embolic agents - Market size and forecast (2024-2029) ($ million)
- Data Table on Liquid embolic agents - Market size and forecast (2024-2029) ($ million)
- Chart on Liquid embolic agents - Year-over-year growth (2024-2029) (%)
- Data Table on Liquid embolic agents - Year-over-year growth (2024-2029) (%)
9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share (2024-2029) (%)
- Data Table on End-user - Market share (2024-2029) (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Hospitals - Market size and forecast (2024-2029)
- Chart on Hospitals - Market size and forecast (2024-2029) ($ million)
- Data Table on Hospitals - Market size and forecast (2024-2029) ($ million)
- Chart on Hospitals - Year-over-year growth (2024-2029) (%)
- Data Table on Hospitals - Year-over-year growth (2024-2029) (%)
- 9.4 Ambulatory surgical centers (ASCs) - Market size and forecast (2024-2029)
- Chart on Ambulatory surgical centers (ASCs) - Market size and forecast (2024-2029) ($ million)
- Data Table on Ambulatory surgical centers (ASCs) - Market size and forecast (2024-2029) ($ million)
- Chart on Ambulatory surgical centers (ASCs) - Year-over-year growth (2024-2029) (%)
- Data Table on Ambulatory surgical centers (ASCs) - Year-over-year growth (2024-2029) (%)
- 9.5 Stroke centers - Market size and forecast (2024-2029)
- Chart on Stroke centers - Market size and forecast (2024-2029) ($ million)
- Data Table on Stroke centers - Market size and forecast (2024-2029) ($ million)
- Chart on Stroke centers - Year-over-year growth (2024-2029) (%)
- Data Table on Stroke centers - Year-over-year growth (2024-2029) (%)
- 9.6 Specialty clinics - Market size and forecast (2024-2029)
- Chart on Specialty clinics - Market size and forecast (2024-2029) ($ million)
- Data Table on Specialty clinics - Market size and forecast (2024-2029) ($ million)
- Chart on Specialty clinics - Year-over-year growth (2024-2029) (%)
- Data Table on Specialty clinics - Year-over-year growth (2024-2029) (%)
- 9.7 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
- 9.8 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- Chart on Application - Market share (2024-2029) (%)
- Data Table on Application - Market share (2024-2029) (%)
- 10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 10.3 Ischemic stroke - Market size and forecast (2024-2029)
- Chart on Ischemic stroke - Market size and forecast (2024-2029) ($ million)
- Data Table on Ischemic stroke - Market size and forecast (2024-2029) ($ million)
- Chart on Ischemic stroke - Year-over-year growth (2024-2029) (%)
- Data Table on Ischemic stroke - Year-over-year growth (2024-2029) (%)
- 10.4 Arteriovenous malformation (AVM) - Market size and forecast (2024-2029)
- Chart on Arteriovenous malformation (AVM) - Market size and forecast (2024-2029) ($ million)
- Data Table on Arteriovenous malformation (AVM) - Market size and forecast (2024-2029) ($ million)
- Chart on Arteriovenous malformation (AVM) - Year-over-year growth (2024-2029) (%)
- Data Table on Arteriovenous malformation (AVM) - Year-over-year growth (2024-2029) (%)
- 10.5 Aneurysm treatment - Market size and forecast (2024-2029)
- Chart on Aneurysm treatment - Market size and forecast (2024-2029) ($ million)
- Data Table on Aneurysm treatment - Market size and forecast (2024-2029) ($ million)
- Chart on Aneurysm treatment - Year-over-year growth (2024-2029) (%)
- Data Table on Aneurysm treatment - Year-over-year growth (2024-2029) (%)
- 10.6 Carotid artery disease - Market size and forecast (2024-2029)
- Chart on Carotid artery disease - Market size and forecast (2024-2029) ($ million)
- Data Table on Carotid artery disease - Market size and forecast (2024-2029) ($ million)
- Chart on Carotid artery disease - Year-over-year growth (2024-2029) (%)
- Data Table on Carotid artery disease - Year-over-year growth (2024-2029) (%)
- 10.7 Venous sinus thrombosis - Market size and forecast (2024-2029)
- Chart on Venous sinus thrombosis - Market size and forecast (2024-2029) ($ million)
- Data Table on Venous sinus thrombosis - Market size and forecast (2024-2029) ($ million)
- Chart on Venous sinus thrombosis - Year-over-year growth (2024-2029) (%)
- Data Table on Venous sinus thrombosis - Year-over-year growth (2024-2029) (%)
- 10.8 Tumor embolization - Market size and forecast (2024-2029)
- Chart on Tumor embolization - Market size and forecast (2024-2029) ($ million)
- Data Table on Tumor embolization - Market size and forecast (2024-2029) ($ million)
- Chart on Tumor embolization - Year-over-year growth (2024-2029) (%)
- Data Table on Tumor embolization - Year-over-year growth (2024-2029) (%)
- 10.9 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
11 Market Segmentation by Procedure Type
- 11.1 Market segments
- Chart on Procedure Type - Market share (2024-2029) (%)
- Data Table on Procedure Type - Market share (2024-2029) (%)
- 11.2 Comparison by Procedure Type
- Chart on Comparison by Procedure Type
- Data Table on Comparison by Procedure Type
- 11.3 Endovascular embolization - Market size and forecast (2024-2029)
- Chart on Endovascular embolization - Market size and forecast (2024-2029) ($ million)
- Data Table on Endovascular embolization - Market size and forecast (2024-2029) ($ million)
- Chart on Endovascular embolization - Year-over-year growth (2024-2029) (%)
- Data Table on Endovascular embolization - Year-over-year growth (2024-2029) (%)
- 11.4 Thrombectomy - Market size and forecast (2024-2029)
- Chart on Thrombectomy - Market size and forecast (2024-2029) ($ million)
- Data Table on Thrombectomy - Market size and forecast (2024-2029) ($ million)
- Chart on Thrombectomy - Year-over-year growth (2024-2029) (%)
- Data Table on Thrombectomy - Year-over-year growth (2024-2029) (%)
- 11.5 Angioplasty and stenting - Market size and forecast (2024-2029)
- Chart on Angioplasty and stenting - Market size and forecast (2024-2029) ($ million)
- Data Table on Angioplasty and stenting - Market size and forecast (2024-2029) ($ million)
- Chart on Angioplasty and stenting - Year-over-year growth (2024-2029) (%)
- Data Table on Angioplasty and stenting - Year-over-year growth (2024-2029) (%)
- 11.6 Flow diversion - Market size and forecast (2024-2029)
- Chart on Flow diversion - Market size and forecast (2024-2029) ($ million)
- Data Table on Flow diversion - Market size and forecast (2024-2029) ($ million)
- Chart on Flow diversion - Year-over-year growth (2024-2029) (%)
- Data Table on Flow diversion - Year-over-year growth (2024-2029) (%)
- 11.7 Tumor embolization - Market size and forecast (2024-2029)
- Chart on Tumor embolization - Market size and forecast (2024-2029) ($ million)
- Data Table on Tumor embolization - Market size and forecast (2024-2029) ($ million)
- Chart on Tumor embolization - Year-over-year growth (2024-2029) (%)
- Data Table on Tumor embolization - Year-over-year growth (2024-2029) (%)
- 11.8 Market opportunity by Procedure Type
- Market opportunity by Procedure Type ($ million)
- Data Table on Market opportunity by Procedure Type ($ million)
12 Market Segmentation by Material Type
- 12.1 Market segments
- Chart on Material Type - Market share (2024-2029) (%)
- Data Table on Material Type - Market share (2024-2029) (%)
- 12.2 Comparison by Material Type
- Chart on Comparison by Material Type
- Data Table on Comparison by Material Type
- 12.3 Nitinol-based devices - Market size and forecast (2024-2029)
- Chart on Nitinol-based devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Nitinol-based devices - Market size and forecast (2024-2029) ($ million)
- Chart on Nitinol-based devices - Year-over-year growth (2024-2029) (%)
- Data Table on Nitinol-based devices - Year-over-year growth (2024-2029) (%)
- 12.4 Cobalt-chromium-based devices - Market size and forecast (2024-2029)
- Chart on Cobalt-chromium-based devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Cobalt-chromium-based devices - Market size and forecast (2024-2029) ($ million)
- Chart on Cobalt-chromium-based devices - Year-over-year growth (2024-2029) (%)
- Data Table on Cobalt-chromium-based devices - Year-over-year growth (2024-2029) (%)
- 12.5 Polymer-based devices - Market size and forecast (2024-2029)
- Chart on Polymer-based devices - Market size and forecast (2024-2029) ($ million)
- Data Table on Polymer-based devices - Market size and forecast (2024-2029) ($ million)
- Chart on Polymer-based devices - Year-over-year growth (2024-2029) (%)
- Data Table on Polymer-based devices - Year-over-year growth (2024-2029) (%)
- 12.6 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)
- 12.7 Market opportunity by Material Type
- Market opportunity by Material Type ($ million)
- Data Table on Market opportunity by Material Type ($ million)
13 Customer Landscape
- 13.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
14 Geographic Landscape
- 14.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 14.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 14.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 14.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 14.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 14.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 14.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 14.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 14.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 14.10 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 14.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 14.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 14.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 14.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 14.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 14.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 14.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
15 Drivers, Challenges, and Opportunity/Restraints
- 15.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 15.4 Market opportunities/restraints
16 Competitive Landscape
- 16.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 16.3 Landscape disruption
- Overview on factors of disruption
- 16.4 Industry risks
- Impact of key risks on business
17 Competitive Analysis
- 17.2 Company ranking index
- 17.3 Market positioning of companies
- Matrix on companies position and classification
- 17.4 BALT Group
- BALT Group - Overview
- BALT Group - Product / Service
- BALT Group - Key offerings
- SWOT
- 17.5 Cook Group Inc.
- Cook Group Inc. - Overview
- Cook Group Inc. - Product / Service
- Cook Group Inc. - Key offerings
- SWOT
- 17.6 Johnson and Johnson
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- 17.7 Kaneka Corp.
- Kaneka Corp. - Overview
- Kaneka Corp. - Business segments
- Kaneka Corp. - Key news
- Kaneka Corp. - Key offerings
- Kaneka Corp. - Segment focus
- SWOT
- 17.8 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 17.9 Penumbra Inc.
- Penumbra Inc. - Overview
- Penumbra Inc. - Product / Service
- Penumbra Inc. - Key offerings
- SWOT
- 17.10 Rapid Medical Ltd.
- Rapid Medical Ltd. - Overview
- Rapid Medical Ltd. - Product / Service
- Rapid Medical Ltd. - Key offerings
- SWOT
- 17.11 Shape Memory Medical Inc.
- Shape Memory Medical Inc. - Overview
- Shape Memory Medical Inc. - Business segments
- Shape Memory Medical Inc. - Key offerings
- Shape Memory Medical Inc. - Segment focus
- SWOT
- 17.12 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key news
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 17.13 Terumo Corp.
- Terumo Corp. - Overview
- Terumo Corp. - Business segments
- Terumo Corp. - Key news
- Terumo Corp. - Key offerings
- Terumo Corp. - Segment focus
- SWOT
- 17.14 Wallby Medical LLC
- Wallby Medical LLC - Overview
- Wallby Medical LLC - Product / Service
- Wallby Medical LLC - Key offerings
- SWOT
18 Appendix
- 18.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 18.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 18.4 Research methodology
- 18.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 18.9 360 degree market analysis
- 360 degree market analysis
- 18.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
